The addition of parameters based on albumin and CRP, but not dNLR, to a base model including age, chromogranin A, the cell proliferation marker Ki‐67, performance status, tumour site and previous treatments improved the predictive accuracy of the base model. This evidence concerns the gene ALB and neoplasm.